These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27435025)

  • 1. Evaluating the case for trivalent or quadrivalent influenza vaccines.
    Baxter D
    Hum Vaccin Immunother; 2016 Oct; 12(10):2712-2717. PubMed ID: 27435025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP
    PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluarix quadrivalent vaccine for influenza.
    Graaf Hd; Faust SN
    Expert Rev Vaccines; 2015; 14(8):1055-63. PubMed ID: 26098443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012.
    Heikkinen T; Ikonen N; Ziegler T
    Clin Infect Dis; 2014 Dec; 59(11):1519-24. PubMed ID: 25139969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.
    Toback SL; Levin MJ; Block SL; Belshe RB; Ambrose CS; Falloon J
    Expert Rev Vaccines; 2012 Nov; 11(11):1293-303. PubMed ID: 23151111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): a review of its use in the prevention of disease caused by influenza A and B.
    McKeage K
    Drugs; 2013 Sep; 73(14):1587-94. PubMed ID: 24022123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-mismatched influenza B/Yamagata lineage viruses in Cuba, 2012-2013 season.
    Arencibia A; Piñón A; Acosta B; Fernandez L; Muné M; Valdés O; Savón C; Oropesa S; Gonzalez G; Roque R; Gonzalez G; Hernández B; Alfonso JM
    Infect Genet Evol; 2018 Mar; 58():110-114. PubMed ID: 29229320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.
    Reed C; Meltzer MI; Finelli L; Fiore A
    Vaccine; 2012 Mar; 30(11):1993-8. PubMed ID: 22226861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quadrivalent influenza vaccine: What is changed and what are the benefits?].
    Mosnier A; Launay O; Martinez L; Gavazzi G; Josset L; Crepey P; Hannoun C; Weil-Olivier C; Gaillat J
    Presse Med; 2018 Oct; 47(10):842-853. PubMed ID: 30219205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season].
    de Jong JC; Rimmelzwaan GF; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2007 Sep; 151(39):2158-65. PubMed ID: 17957994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving history of influenza viruses and influenza vaccines.
    Hannoun C
    Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Debate on the compositions of influenza B in northern hemisphere seasonal influenza vaccines.
    He G; Yang P; Yan Q; Xiong C
    Antimicrob Resist Infect Control; 2019; 8():164. PubMed ID: 31673353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rationale for quadrivalent influenza vaccines.
    Ambrose CS; Levin MJ
    Hum Vaccin Immunother; 2012 Jan; 8(1):81-8. PubMed ID: 22252006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference.
    Bandell A; Woo J; Coelingh K
    Expert Rev Vaccines; 2011 Aug; 10(8):1131-41. PubMed ID: 21854309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.
    Camilloni B; Neri M; Lepri E; Iorio AM
    Vaccine; 2009 Jun; 27(31):4099-103. PubMed ID: 19410623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
    Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
    Bekkat-Berkani R; Ray R; Jain VK; Chandrasekaran V; Innis BL
    Expert Rev Vaccines; 2016; 15(2):201-14. PubMed ID: 26641539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology and genetic characterization of influenza B virus in Lebanon during 2016-2018.
    AlIbrahim M; Assaf-Casals A; Massaad E; Shaker R; Soudani N; Fayad D; Chamseddine S; Lteif-Khoury M; Chmaisse A; Isaac I; Anan H; Sadaka C; Radwan N; Ghanem S; Naous A; Karam M; Andary R; Dbaibo G; Zaraket H
    Infect Genet Evol; 2019 Nov; 75():103969. PubMed ID: 31325610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.